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Whereas high-avidity recognition of peptide-MHC
complexes by developing T cells in the thymus re-
sults in deletion and promotes self-tolerance, such
recognition by mature T cells in the periphery results
in activation and clonal expansion. This dichotomy
represents the basis of a dilemma that has stumped
immunologists for many years, how are self-specific
T cells tolerized in the periphery? There appear to be
two important criteria used to achieve this goal. The
first is that in the absence of inflammatory pathogens,
tolerance is promoted when T cells recognize antigen
presented by quiescent dendritic cells (DCs) express-
ing low levels of costimulatory molecules. A second
critical factor that defines “self” and drives tolerance
through deletion, anergy, or suppression is the per-
sistence of antigen.
Peripheral Tolerance: What's It Good For?
Elimination of potentially autoreactive T cells is an im-
portant part of T cell development in the thymus. Al-
though TCR-mediated recognition of self-peptide-MHC
complexes by developing T cells is necessary to signal
further maturation (Starr et al., 2003), immature T cells
(thymocytes) that exhibit high-affinity recognition of
self-peptide-MHC complexes could potentially contrib-
ute to autoimmunity and, therefore, are deleted by a
process referred to as negative selection or central tol-
erance (Starr et al., 2003). Thymocytes are exposed to
self-antigens presented as peptide-MHC (pMHC) com-
plexes by bone marrow (BM)-derived, antigen-pre-
senting DCs. DCs present endogenously expressed an-
tigens as well as exogenous antigens acquired through
endocytic and phagocytic pathways, a process referred
to as crosspresentation (Heath and Carbone, 2001;
Mellman and Steinman, 2001).
In addition to DCs, recent work has implicated thymic
epithelial cells (TECs) as potential mediators of nega-
tive selection (Palmer, 2003). Interestingly, TECs are
able to constitutively synthesize and express many pe-
ripheral tissue-specific antigens that would otherwise
be unavailable to induce thymic tolerance, a function
that was recently shown to be dependent upon expres-
sion of the autoimmune regulator (AIRE) gene (Ander-
son et al., 2002). TEC-dependent expression of self-
antigens is an important mechanism to help eliminate
autoreactive cells as AIRE-deficient humans and mice
develop organ-specific autoimmunity (The Finnish-Ger-*Correspondence: lsherman@scripps.edu
2Present address: Earle A. Chiles Research Institute, Robert W.
Franz Cancer Research Center, Providence Portland Medical Cen-
ter, 4805 NE Glisan St., Portland, Oregon 97213.man APECED Consortium, 1997; Anderson et al., 2002;
Ramsey et al., 2002). Furthermore, a recent report dem-
onstrated that TEC-mediated central tolerance could
occur via recognition of antigen displayed by the TECs
themselves or after transfer of the antigens to BM-
derived, antigen-presenting cells (APCs) (Gallegos and
Bevan, 2004).
Considering that the T cell repertoire is carefully
purged of potentially autoreactive T cells in the thymus,
the question arises as to whether additional tolerance
mechanisms are necessary in the periphery. One
reason such mechanisms are required is to avoid the
development of an immune response against the myr-
iad of innocuous environmental antigens to which we
are continuously exposed, both from our diet and envi-
ronment (Huang et al., 2000; Mowat, 2003). Furthermore,
there are severe limitations on the ability of central tol-
erance to delete all potentially autoreactive T cells. De-
spite the activity of AIRE, not all self-antigens are ex-
pressed in the thymus at levels sufficient to eliminate all
autoreactive cells. Indeed, although negative selection
deletes T cells of high avidity for self-antigens, low-
avidity T cells that have much less chance of initiating
autoimmunity are spared (Liu et al., 1995; Morgan et al.,
1998). This cutoff in avidity threshold is an important
investment in repertoire diversity at the expense of re-
taining certain potentially autoreactive cells.
Because the affinity threshold of TCR-pMHC interac-
tion that signals thymic deletion is lower than that for
activation in the periphery (Pircher et al., 1991), it is
likely that some T cells with low avidity for self-antigens
will not be activated in the periphery and, instead, re-
main “ignorant” of their cognate antigen (Ohashi et al.,
1991; Oldstone et al., 1991). In effect, autoreactive T
cell responses are prevented by simply avoiding re-
cognition of the self-protein either through physical re-
striction of the antigen to an immunologically privileged
location or due to low TCR avidity for the cognate anti-
gen. However, ignorance of the antigen is an inherently
dangerous mechanism and cannot be relied upon to
maintain peripheral tolerance because, given the proper
stimulatory milieu, such antigens may no longer be ig-
nored and could potentially initiate autoimmune re-
sponses. Indeed, it has been shown that viral priming
can break CD8 T cell ignorance and promote autoim-
munity (Ohashi et al., 1991; Oldstone et al., 1991).
There is, however, one distinct disadvantage to post-
poning tolerance until after the self-reactive T cell
reaches the periphery—thymocytes and mature T cells
respond differently to TCR signaling. In contrast to thy-
mocytes, which are deleted by a strong TCR signal
without signaling cellular division, a strong TCR signal
in mature T cells is hard wired to initiate division (Gett et
al., 2003; Kishimoto and Sprent, 1997). For this reason,
peripheral tolerance mechanisms must deal not only
with the autoreactive T cell but also with its clonal prog-
eny. Therefore, it is advantageous to eliminate as many
potentially harmful cells as possible during thymic de-
velopment.
In summary, although central tolerance is a critical
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276step in purging the repertoire of autoreactive T cells, t
sthe additional layers of protection provided by periph-
seral tolerance mechanisms are required to maintain
uself-tolerance in vivo. This review focuses on peripheral
ptolerance mechanisms that act directly on CD8 T cells,
pas opposed to dominant tolerance mechanisms that in-
avolve inhibition by regulatory T cells, as may occur in
aimmunologically privileged sites (Sakaguchi, 2004). It is
”likely that many of the same mechanisms discussed
sbelow for CD8 T cells also relate to CD4 T cell periph-
teral tolerance. Moreover, the word tolerance is used in
la broad sense to include all situations in which TCR
precognition and activation fail to stimulate a protective
simmune response.
t
rThe Role of DCs in Defining Self/Nonself
mDiscrimination in the Periphery
pNewly minted T cells express high levels of CD62L, a
pmolecule that promotes the entry of T cells from blood
mto lymph nodes (Weninger et al., 2001). This confines
2naive T cells exported from the thymus to a pattern of
scirculation between blood and secondary lymphoid tis-
Tsues (Mackay, 1993). It may be argued that with such
pa restricted range of movement, T cells would never
Cencounter peripheral antigens. However, DCs are
ccharged with the task of acquiring antigens from pe-
vripheral tissue and traveling to draining lymph nodes
twhere the antigen is crosspresented to naive CD8 T
ccells (Heath and Carbone, 2001). This is a constitutive
lprocess that allows CD8 T cells in lymph nodes to be-
come acquainted with all antigens expressed in the pe-
f
ripheral tissue. Tissue-resident DCs are believed to
c
acquire antigens during phagocytic clearance of apo-
s
ptotic cells arising from normal cell turnover and then
h
migrate to the lymph nodes that drain the tissue (Albert
t
et al., 1998; Belz et al., 2002; Iyoda et al., 2002). After a
processing and presenting these acquired antigens as T
peptides associated with MHC class I molecules, the h
DCs are able to stimulate naive CD8 T cells (Ingulli et a
al., 1997). t
In this way, all systemically and peripherally ex- i
pressed antigens can be presented to naive CD8 T cells s
circulating through the secondary lymphoid tissue. This p
provides an opportunity for CD8 T cells that recognize b
peripheral self-antigens with high avidity to be acti- D
vated. In the absence of pathogens, however, DCs are S
quiescent and express low levels of costimulatory T
molecules, such as B7.1 and B7.2 (Steinman et al., o
2003). These molecules interact with CD28 on T cells c
to enhance T cell responsiveness and survival (Boise et d
al., 1995). As a result, high-avidity recognition of anti- s
gen in the absence of costimulation through CD28 re-
sults in T cell activation characterized by only a brief s
period of proliferation and suboptimal development of n
effector cell function (Hernandez et al., 2001; Kearney i
et al., 1994). The end result is the induction of T cell i
tolerance, which can occur by one of two mechanisms, a
deletion or anergy. Anergy represents a state of func- I
tional unresponsiveness that is actively supported by o
the presence of antigen, as discussed further below. t
In contrast, upon infection by a pathogen, tissue-res- t
ident DCs are activated by inflammatory cytokines and o
through pattern recognition molecules, such as toll-like b
receptors, that are designed to detect conserved bac-erial and viral products and alert the innate immune
ystem of the presence of the invading microbes (Iwa-
aki and Medzhitov, 2004). These are, in effect, the nat-
ral adjuvants that promote an immune response. This
rocess of DC activation results in enhanced antigen
resentation, production of inflammatory cytokines,
nd importantly, increased levels of expression of B7.1
nd B7.2 costimulatory molecules. Such DCs are now
licensed” to activate T cells. Although a strong TCR
ignal is sufficient to initiate cell division, additional in-
eractions between costimulatory molecules and their
igands, such as CD28-B7, as well as the presence of
roinflammatory cytokines are critical to support T cell
urvival and optimize the development of effector func-
ions (Lenschow et al., 1996). Signaling through CD28
esults in the enhanced expression of antiapoptotic
olecules, such as Bcl-xL (Boise et al., 1995), which
romote the survival of clonal progeny and signals ex-
ression of a cascade of downstream costimulatory
olecules that further promote cell survival (Croft,
003). Costimulatory signals also modulate the expres-
ion of molecules that permit activated effector CD8
cells to leave the lymphoid tissue and migrate into
eripheral tissues. This includes the downregulation of
D62L and CCR7 and upregulation of adhesion mole-
ules, such as LFA-1 and VLA-4, which facilitate extra-
asation of the activated CD8 T cells into peripheral
issues, thus allowing the cells to participate in the
learance of pathogens from peripheral tissues (Sal-
usto et al., 1999).
Other mechanisms are also capable of licensing DCs
or CD8 T cell activation (Smith et al., 2004). These in-
lude activating DCs through costimulatory molecules,
uch as CD40 and B7. Activated CD4 T cells express
igh levels of CD40L that can stimulate DC maturation
hrough interaction with CD40 on the DC (Bennett et
l., 1998; Ridge et al., 1998; Schoenberger et al., 1998).
his is an important way in which CD4 T cells provide
elp for a CD8 T cell response. In addition to CD40, it
ppears that CD28 on activated CD8 T cells can
ransmit stimulatory signals to DCs through CD28-B7
nteractions (Orabona et al., 2004). The existence of
uch a “back-stimulation” pathway helps to explain
revious reports in which it was found that large num-
ers of activated CD8 T cells are capable of inducing
C activation (Mintern et al., 2002; Ruedl et al., 1999;
chuler and Blankenstein, 2002; Wang et al., 2001).
his observation also sheds light on how large numbers
f cognate CD8 T cells supply their own “help” that
an result in tissue destruction, eventually leading to
iabetes (Kurts et al., 1997a) or tumor eradication (Han-
on et al., 2000; Lyman et al., 2004; Nguyen et al., 2002).
The prevailing paradigm that explains tolerance ver-
us immunity is as follows: Invading pathogens an-
ounce their presence through activation of a variety of
nnate immune signals, including recognition by innate
mmune receptors on DCs, which lead to DC activation
nd a vigorous immune response to cognate antigens.
n contrast, self-antigen that is constitutively presented
n quiescent DCs leads to a quantitatively and qualita-
ively different type of response, specifically the induc-
ion of tolerance. Furthermore, there have been numer-
us examples in which the same soluble antigen can
e shown to be tolerogenic or immunogenic to CD8 Tcells, depending upon whether it is delivered with adju-
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277vant (Lefrancois et al., 2000; Schmidt and Mescher,
1999). Therefore, it may be concluded that an important
component of self/nonself discrimination in the peri-
phery is the activation status of the antigen-present-
ing DC.
The Role of Antigen Persistence
in Tolerance Induction
Experiments using several different CD8 TCR trans-
genic models have lent support to another explanation
for self/nonself recognition that places the responsibil-
ity for this decision on the persistence of antigen rather
than on the presence of adjuvant (Aichele et al., 1995;
Rocha and von Boehmer, 1991). Rocha and coworkers
performed a particularly elegant experiment using the
HY (male antigen)-specific model. They produced chi-
meras expressing different numbers of HY-bearing
male cells and then introduced HY-specific CD8 T cells
(Rocha et al., 1995). In all cases, the T cells initially pro-
liferated and exhibited some effector function. In mice
that contained few HY-expressing cells, this initial acti-
vation resulted in complete elimination of the antigen-
bearing cells, and the activated T cells went on to be-
come memory cells. In contrast, in mice that contained
a larger number of HY cells, the T cells were gradually
tolerized (Rocha et al., 1995). These studies demon-
strated that it was possible to develop an effector T cell
response in the absence of adjuvant. The variable that
appeared to determine whether the activation condi-
tions led to the development of memory T cells or toler-
ance induction was the persistence of antigen.
Zinkernagel and coworkers obtained analogous re-
sults by using a different CD8 TCR transgenic specific
for a peptide from the glycoprotein of the lymphocytic
choriomeningitis virus (LCMV). They found that delivery
of a single dose of peptide to mice containing viral gly-
coprotein (GP)-specific CD8 T cells resulted in T cell
priming and memory cell formation, as defined by fur-
ther protection from infection with LCMV, whereas
multiple doses resulted in tolerance (Aichele et al.,
1995). In this case, CD8 T cell tolerance appeared to
occur by deletion. Based upon these results, Zinkerna-
gel proposed a tolerance model in which antigen local-
ization, dose, and persistence are the critical factors
that determine tolerance induction, rather than just the
delivery of costimulating signals by the antigen-pre-
senting cells (Zinkernagel, 2000).
Surprisingly, it has also been found that CD8 T cells
activated in the persistent presence of a pathogen can
undergo tolerance. Zajac et al. examined CD8 T cell
responses during a viral infection and showed that per-
sistent infection with LCMV led to an initial CD8 T cell
response that was followed by the induction of anergy
in the remaining cells (Zajac et al., 1998). This effect
appeared to be antigen dependent, as use of an acute
infecting strain of LCMV that was rapidly cleared did
not cause CD8 T cell nonresponsiveness.
The above experiments support a model of self/non-
self recognition that is based upon antigen persistence,
as the same activation conditions that led to an im-
mune response and memory cell development could
also result in tolerance. In fact, the critical difference
between these divergent outcomes was the persis-
tence of antigen rather than the activation status of
the APC.Comparing the Relative Importance of Antigen
Persistence and DC Activation
in Tolerance Induction
To further assess the relative contribution of DC activa-
tion and antigen persistence in CD8 T cell tolerance
induction, we performed an experiment in which each
of these variables was considered (Redmond et al.,
2003). Clone 4 TCR transgenic CD8 T cells, specific
for the influenza hemagglutinin (HA), were adoptively
transferred into mice in which HA was crosspresented
by activated (anti-CD40 mAb or influenza virus-treated
mice) or quiescent (nontreated mice) DCs. After 4 days,
the cells were recovered, and the effector status of the
activated clone 4 T cells was examined. As expected,
the activation status of the DC was important in terms
of affecting the differentiation of naive CD8 T cells into
effector CTL (Figure 1) as effector functions were exhib-
ited by clone 4 T cells recovered from virus or anti-
CD40 mAb-treated mice. In contrast, clone 4 T cells
activated by quiescent DCs exhibited weak effector
functions.
Next, we addressed whether the activation status of
the DCs affected survival of the CD8 T cells. Day 4 after
activation, clone 4 T cells were removed from the host
in which they were activated and then transferred into
antigen-free recipients. After several weeks, the anti-
gen-free hosts were challenged with influenza virus to
reveal the presence of antigen-responsive clone 4 T
cells. Surprisingly, regardless of the initial stimulatory
conditions, a portion of the activated CD8 T cells sur-
vived and responded fully to virus. In contrast, if the
cells were transferred into antigen-bearing hosts, then
regardless of the activation status of the antigen-pre-
senting DCs, the clone 4 T cells were tolerized (Figure
1). These results demonstrate that the effector status
of a CD8 T cell does not affect its decision to undergo
tolerance or deletion, as effectors can be tolerized (in
antigen-bearing hosts), and CD8 T cells that have no
effector activity can become memory cells (in antigen-
free hosts).
Importantly, for at least several days after their initial
activation by quiescent DCs, the progeny of the acti-
vated CD8 T cells had not fully committed to undergo
clonal deletion, as at least a portion of the cells survive
and can regain responsiveness if removed from the
presence of antigen. Rather, further exposure to anti-
gen appears to be required in order to induce all CD8
T cells and their clonal progeny to undergo tolerance.
This requirement for sustained antigenic exposure to
promote complete clonal elimination ensures that only
those autoreactive CD8 T cells that encounter persis-
tently expressed self-antigens undergo clonal elimina-
tion while sparing from deletion CD8 T cells that may
recognize a transiently expressed antigen, such as an
environmental or food-derived antigen.
Does Tolerance to a Persistently Expressed
Antigen Occur if the Antigen Is Presented
by an Activated APC?
Several groups have demonstrated that chronic infec-
tions can lead to the induction of T cell anergy
(Bronstein-Sitton et al., 2003; Zajac et al., 1998), sug-
gesting that tolerance can occur even if antigen is pre-
sented in the presence of a pathogen. However, recent
Immunity
278Figure 1. Activated APCs Program the Acquisition of CD8 T Cell Effector Functions, but Chronic Exposure to Antigen Is Required for Toler-
ance Induction
Stimulation of naive CD8 T cells by peptide-MHC (pMHC) on activated DCs expressing high levels of costimulatory molecules leads to CD8
T cell proliferation and differentiation into IFN-γ producing cytolytic effector cells. Costimulation also increases levels of antiapoptotic mole-
cules, which promote survival of the effectors. In contrast, activation of naive CD8 T cells by quiescent DCs does not promote increased
levels of antiapoptotic molecules and, therefore, leads to an abbreviated proliferative response. Additionally, the cells acquire little or no
effector functions. Importantly, in both cases, antigen clearance promotes CD8 T cell survival and production of memory cells, whereas
chronic antigenic stimulation (see +Ag) leads to tolerance.work has demonstrated the ability of certain pathogens a
to downmodulate the activation status of the APC (Sev- R
illa et al., 2004) and thereby inhibit the normal proin- d
flammatory response that would promote naive CD8 T t
cell differentiation into effector CTL. As a result, it be- a
comes difficult to isolate the relative contribution of an- 1
tigen persistence versus the activation status of the r
APC in the induction of CD8 T cell tolerance. Further- r
more, the presence of a pathogen leads to the involve- e
ment of numerous factors that influence the outcome m
of the response, including the activation of multiple a
components of the innate and adaptive immune sys- t
tem, such as CD4 helper and regulatory T cells. e
Mayerova et al. have demonstrated that even in the m
absence of pathogen, it may not be possible to achieve r
tolerance to a persistently expressed antigen that is i
presented by activated APCs (Mayerova et al., 2004). i
They examined CD8 T cell responses to self-antigen
presented by Langerhans cells, a unique epidermal
pAPC that is constitutively activated. Under these condi-
ptions, priming, rather than tolerance, of naive CD8 T
ocells was induced, which ultimately led to the onset of
sautoimmunity. Interestingly, when the same antigen
twas also expressed elsewhere in the animal, resulting
Cin crosspresentation by both activating as well as tolero-
lgenic APCs, tolerance was the dominant outcome,
psuggesting a possible regulatory mechanism to prevent
psuch autoimmune responses in a wild-type (wt) host.
i
sThe Fate of Tolerized CD8 T Cells In Vivo:
pAnergy versus Deletion?
cPeripheral tolerance of CD8 T cells can occur throughanergy or clonal deletion (Kundig et al., 1996; Kurts etl., 1997b; Kyburz et al., 1993; Mamalaki et al., 1993;
ocha et al., 1993). Anergy is an active process that is
ependent upon the continuous presence of antigen as
he cells regain their ability to respond once they are
llowed to rest in the absence of antigen (Rocha et al.,
993; Schwartz, 2003). Numerous questions remain un-
esolved regarding the underlying mechanisms that
egulate this decision and the biological significance of
ach mechanism in vivo. At least some of the confusion
ay be due to the fact that, regardless of whether toler-
nce occurs through anergy or complete clonal dele-
ion, the initial period of proliferation in response to tol-
rogen is followed by a period of contraction in which
ost of the cells undergo apoptosis, just as during a
esponse to pathogen (Badovinac et al., 2002). Thus, at
ssue is the fate of a relatively small number of surviv-
ng cells.
There is increasing evidence that in the presence of
ersistent antigen, the fate of naive CD8 T cells during
eripheral tolerance may be determined by the strength
f interaction between the TCR and pMHC. As de-
cribed earlier, studies from Rocha et al. demonstrated
he ability of high doses of chronic antigen to promote
D8 T cell anergy, whereas lower doses resulted in de-
etion (Rocha et al., 1995). In our own studies, we com-
ared the response of clone 4 T cells to continuous
rovision of high versus low doses of peptide tolerogen
n vivo, and we too have found that continuous expo-
ure of naive clone 4 T cells to high doses of soluble
eptide induced anergy in a portion of the responding
ells, whereas continuous exposure to low doses re-
sulted in clonal deletion (Redmond et al., 2005, and Fig-
Review
279Figure 2. Strength of TCR-pMHC Interaction
in CD8 T Cell Peripheral Tolerance
Activation of naive CD8 T cells under tolero-
genic conditions promotes their initial prolif-
eration followed by the induction of apopto-
sis in most of the responding CD8 T cells.
Chronic exposure to strong TCR signals
(high doses of antigen) renders the CD8 T
cell anergic, or nonresponsive, to additional
stimulation. Persistence of a strong TCR sig-
nal is required to maintain anergy. In con-
trast, persistence of a weak TCR signal (low
doses of antigen) leads to complete clonal
deletion. Finally, the induction of CD8 T cell
anergy or deletion is dependent upon chronic
antigenic stimulation as a portion of the tol-
erized CD8 T cells can survive long term in
vivo once they are removed from the pres-
ence of antigen.ure 2). Thus, anergy appears to be an effective way to
preserve cells via an underlying mechanism that relates
to the strength of TCR-pMHC interaction.
TCR-induced activation of Ras and down-stream in-
tracellular signaling molecules, such as ERK, are inhib-
ited in anergic T cells (DeSilva et al., 1996; Fields et al.,
1996; Li et al., 1996). Phospho-ERK is a tyrosine kinase
that regulates the activation of down-stream molecules
that are critical for optimal proliferation and differentia-
tion of naive T cells (Cantrell, 1996; Dong et al., 2002).
To determine whether the strength of TCR-pMHC in-
teraction relates to the decision to undergo deletion
versus anergy, clone 4 T cells were first exposed to vary-
ing doses of HA peptide in vivo. After several days, the
cells were recovered, and their ability to upregulate
phospho-ERK in response to stimulation with peptide
was assessed in vitro. We found that clone 4 T cells
activated with high doses of HA peptide in vivo were
unable to upregulate phospho-ERK in response to anti-
gen and that this correlated with their inability to re-
spond to further stimulation through their TCR (Red-
mond et al., 2005). Furthermore, as the level of peptide
declined with time, the anergized clone 4 T cells re-
gained their ability to produce phospho-ERK and to re-
spond to antigen.
In contrast to these results, chronic exposure of
clone 4 T cells to low doses of peptide that could suc-
cessfully induce clonal deletion in vivo was associated
with continuous production of phospho-ERK. These re-
sults suggest that clonal deletion in the periphery re-
quires continuous signal transduction through the Ras-
ERK pathway and that this can only occur when the
strength of TCR-pMHC interaction is below a certain
threshold. This may occur either as the result of expo-
sure of the T cell to low amounts of antigen, a situation
that may be common for crosspresented self-antigens
in vivo, or high amounts of an antigen that is recognized
with low avidity. Before considering what determines
the threshold that is responsible for deletion versus an-
ergy, it is informative to first consider the mechanism
of anergy.
Mechanisms of CD8 T Cell Anergy
The characteristics of CD8 T cells undergoing anergy
are diverse. By using the HY TCR Tg system, Rocha et
al. have shown that the induction of CD8 T cell anergywas associated with downregulation of both TCR and
CD8 molecules (Rocha and von Boehmer, 1991). Inter-
estingly, TCR downregulation occurs in some (Schon-
rich et al., 1991), but not all (Dubois et al., 1998), situa-
tions involving the induction of anergy during chronic
CD8 T cell activation in vivo. We observed minimal TCR
downregulation during peptide-induced clone 4 T cell
anergy (Redmond et al., 2005). Because TCR downreg-
ulation in naive CD8 T cells is dependent upon the TCR
affinity for cognate peptide-MHC class I molecules (Cai
et al., 1997), it is possible that the cells we examined
may not have possessed sufficient affinity for their cog-
nate antigen to promote TCR downregulation during
tolerance induction. In addition to TCR downregulation,
anergic CD8 T cells have been shown to exhibit de-
creased expression of many TCR-associated signaling
molecules, such as ZAP-70, and exhibit defective
calcium responses in response to TCR ligation in vitro
(Guillaume et al., 2003; Tanchot et al., 1998). Further-
more, as mentioned previously, defects in Ras activa-
tion and phosphorylation of down-stream TCR signal-
ing molecules, including ERK, have been reported for
chronically activated CD4 and CD8 T cells, suggesting
that this may be a common mechanism of T cell anergy
in vivo (Dubois et al., 1998; Li et al., 1996; Schwartz,
2003).
Recent studies have shed light on the underlying
mechanism for this plethora of signaling defects. First,
anergy is an active process that occurs as the result of
TCR signaling in the absence of costimulation (Macian
et al., 2002). Such activation results in mobilization of
free calcium and activation of the calcium-sensitive
protein phosphatase calcineurin. Calcineurin dephos-
phorylates the transcriptional activator NFAT, thereby
allowing it to translocate to the nucleus where it in-
duces the transcription of a number of anergy-specific
genes, including Itch, Cbl-b, and GRAIL, ubiquitin li-
gases that are required for CD4 and CD8 T cell anergy
in vivo (Gronski et al., 2004; Jeon et al., 2004). The ab-
sence of Cbl-b lowers the threshold for T cell activa-
tion, as Cbl-b-deficient mice are susceptible to the de-
velopment of autoimmune disease (Bachmaier et al.,
2000; Jeon et al., 2004). Cbl-b is thought to promote
the induction and maintenance of T cell anergy by re-
ducing the level of calcium mobilization that occurs in
response to TCR signaling, a process that is regulated
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280by PLCγ-1. The basis for reduced activity of PLCγ-1 has f
dbeen reported to be both reduced phosphorylation
d(Jeon et al., 2004) and increased degradation (Heiss-
omeyer et al., 2004) of the molecule. Ubiquitination by
aCbl-b tags the protein for lysosomal degradation. This
mappears to be a general method of reducing a number
aTCR signaling molecules in anergic cells, including
mTCR, PLCγ-1, and PKC-θ (Heissmeyer et al., 2004). Col-
nlectively, these data support a model of T cell anergy
ain which persistent engagement of the TCR promotes
icontinuous downregulation of TCR signaling pathways
cthrough activation of anergy-inducing genes.
wNegative regulatory molecules have also been impli-
tcated in the induction and maintenance of CD8 T cell
hanergy. Some reports have shown increased expres-
hsion of the negative regulatory molecule CD5 on the
tsurface of chronically stimulated CD4 and CD8 T cells
e(Hawiger et al., 2004; Stamou et al., 2003). CD5 is
thought to moderate TCR-mediated signaling in both
ithymocytes and mature T cells, and its expression has
dbeen found to increase on high-avidity or chronically
tactivated T cells (Azzam et al., 2001; Azzam et al., 1998;
2Tarakhovsky et al., 1995). Surprisingly, we have not ob-
qserved increased expression of CD5 in anergized CD8
tT cells (our unpublished data). The reasons underlying
athe apparent involvement of CD5 in some, but not all,
models of peripheral tolerance are unknown, but may
ireflect differences in TCR avidity among the various
pmodel systems examined. Indeed, several groups have
dshown that the upregulation of CD5 is related to the
dextent of TCR signaling and avidity for cognate antigen
C(Azzam et al., 1998; Tarakhovsky et al., 1995).
TIt should also be noted that another negative regula-
atory molecule, cytotoxic T lymphocyte antigen 4 (CTLA-4),
swhich plays a key role in the induction of tolerance and
eanergy of CD4 T cells (Greenwald et al., 2001; Perez et
wal., 1997), appears to be dispensable for CD8 T cell an-
aergy (Deeths et al., 1999; Frauwirth et al., 2001).
iA Model of CD8 T Cell Fate pduring Peripheral Tolerance C
It is of interest to consider that regardless of the ulti- t
mate fate of an activated CD8 T cell, initially, all immune c
responses follow a similar pattern—TCR engagement o
signals T cell activation and proliferation. If the cell also t
receives a costimulatory signal, this ensures a robust I
proliferative response that is followed by a contraction c
phase during which up to 95% of the clonal progeny o
die through an apoptotic mechanism (Dutton et al., e
1998). This contraction occurs independently of the (
presence of antigen (Badovinac et al., 2002). In the ab- o
sence of costimulation, the amount of proliferation and i
time to contraction is reduced, and again, the majority v
of cells undergo apoptosis. When viewed in this light, e
the qualitative difference between tolerance and immu- c
nity comes down to the fate of the cells that were capa- i
ble of surviving the contraction phase: the memory cell k
precursors. What happens to these memory cell pre- a
cursors during tolerance induction? Are they never b
formed or, alternatively, are these the cells that must s
be convinced to undergo deletion or anergy in order to a
achieve tolerance? s
tBefore addressing this question, it is necessary toirst consider the signals that contribute to the life and
eath of an activated CD8 T cell during tolerance in-
uction. There is increasing evidence that the survival
f naive T cells in the periphery is largely determined by
balance between endogenous pro- and antiapoptotic
olecules that regulate mitochondrial integrity (Zhu et
l., 2004). In particular, the level of the antiapoptotic
olecule Bcl-2 is maintained in resting T cells by sig-
aling through the IL-7Rα (Schluns et al., 2000). T cell
ctivation leads to downregulation of IL-7Rα, resulting
n decreased expression of these antiapoptotic mole-
ules. At the same time, metabolic activity associated
ith T cell activation and proliferation results in deple-
ion of existing Bcl-2. Because Bcl-2 is required to in-
ibit the activity of Bim, a proapoptotic molecule that
as been implicated in both thymic and peripheral dele-
ion (Bouillet et al., 2002; Hildeman et al., 2002; Mintern
t al., 2002), the result is clonal deletion.
It should be noted that activation induced cell death
nvolving TNFR family members, such as Fas-FasL,
oes not appear to be involved in CD8 T cell peripheral
olerance induced by quiescent DCs (Davey et al.,
002). This may be because the induction of FasL re-
uires increased activation of NF-κβ, which is unlikely
o occur in the absence of costimulation (Teixeiro et
l., 2004).
Several reports have demonstrated that during prim-
ng, a subpopulation of naive CD8 T cells that ex-
resses IL-7Rα and CD8αα preferentially survive and
ifferentiate into memory cells (Kaech et al., 2003; Ma-
akamutil et al., 2004). It has been proposed that
D8αα serves to reduce the strength of signaling to the
cell during stimulation, which may inhibit Fas-medi-
ted cell death that can occur when the cell receives a
trong signal involving both the TCR and CD28 (Teixeiro
t al., 2004). In addition, CD8αα and IL-7Rα signaling
ould enhance production of antiapoptotic molecules
nd allow memory cells to survive.
Given our current knowledge regarding the fate of na-
ve CD8 T cells after chronic antigenic exposure, we
ropose the following model governing the fate of naive
D8 T cells activated under tolerogenic conditions in
he absence of costimulation in vivo: in the absence of
ognate antigen, naive CD8 T cells express high levels
f the IL-7Rα and their survival and homeostatic main-
enance is regulated via signaling by endogenous
L-7 (Figure 3). We propose that during activation under
onditions of weak TCR-pMHC interaction, the amount
f free calcium released is insufficient to activate “an-
rgy” genes. However, the cells downregulate IL-7Rα
Schluns et al., 2000), resulting in decreased expression
f antiapoptotic Bcl-2. As yet, no pathway has been
dentified that specifically links TCR signaling with acti-
ation of proapoptotic molecules such as Bim. How-
ver, activation of the Ras-signaling pathway under
onditions in which the PKC-signaling pathway is inhib-
ted, as may occur in the absence of costimulation, is
nown to promote apoptosis through a Bcl-2-inhibit-
ble pathway (Denis et al., 2003). The increased meta-
olic activity associated with T cell activation and divi-
ion increases production of reactive oxygen species
nd increases the need for antiapoptotic molecules
uch as Bcl-2, thereby further depleting their level in
he cell (Denis et al., 2003; Hildeman et al., 2003). This
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281Figure 3. Model of CD8 T Cell Fate during Peripheral Tolerance: Anergy versus Deletion
In the absence of cognate antigen, the prosurvival cytokine IL-7 promotes continuous production of antiapoptotic molecules that assure
survival of naive CD8 T cells. Exposure to antigen under tolerogenic conditions promotes CD8 T cell proliferation coupled with downregulation
of the IL-7Rα. After this initial clonal burst, most of the proliferating cells are eliminated through an apoptotic mechanism initiated by the
downregulation of the IL-7Rα. A portion of the cells can survive this initial encounter with antigen and, in the presence of chronic antigenic
stimulation, are faced with two fates—deletion or anergy. Weak TCR stimulation is associated with the maintenance of TCR-mediated signal-
ing pathways, which leads to depletion of antiapoptotic molecules, probably through accumulation of reactive oxygen species. This promotes
the activity of the proapoptotic molecule Bim, resulting in CD8 T cell deletion. In contrast, strong TCR stimulation leads to the production of
anergy genes, which subsequently inhibit further TCR-mediated Ras-ERK signaling and, instead, induce CD8 T cell anergy.tips the balance towards death, with involvement of
proapoptotic molecules such as Bim (Hildeman et al.,
2002; Mintern et al., 2002). As long as antigen is present
and TCR signaling continues, IL-7Rα levels remain low,
and the cells continue to die until clonal deletion is
complete. Alternatively, if during this period of time an-
tigen is removed, then a population of cells emerges
that is capable of reexpressing IL-7Rα, which in turn
promotes the expression of antiapoptotic molecules.
These cells would represent the “memory” cells that
have been observed when cells undergoing deletion
are removed from antigen (Redmond et al., 2003). It is
likely that these would be more akin to central rather
than effector memory cells (Sallusto et al., 1999), as
they may not have developed effector functions when
first activated.
In contrast, a different scenario emerges when con-
sidering the activation of naive CD8 T cells that experi-
ence strong signaling during peripheral tolerance. Ini-
tially, the events that occur after activation through
strong or weak TCR engagement are similar. The initial
exposure to antigen leads to a proliferative response,
which is soon followed by the deletion of the majority
of the responding cells (Figure 3). As described above,
this initial activation leads to downregulation of IL-7Rα,
and either through the decrease in antiapoptotic mole-
cules or through a direct TCR-mediated proapoptotic
signal, most (but not all) of the CD8 T cells are elimi-nated. However, with sufficient strength of TCR-antigen
interaction, the levels of free calcium produced are ade-
quate to trigger anergy, which occurs in a portion of the
responding CD8 T cells. This is associated with reduced
Ras-ERK signaling and cessation of the TCR-mediated
proapoptotic signals. It is interesting to speculate that
the anergized cells that survive may represent the pop-
ulation of memory precursors, although it is not known
if they regain expression of IL-7Rα or perhaps utilize
another prosurvival cytokine, such as IL-15. Impor-
tantly, the anergized cells survive and remain nonre-
sponsive to antigen, although paradoxically, the main-
tenance of anergy requires the continuous presence of
antigen, thus some level of signaling through the TCR
must persist in order to sustain the anergized state. In-
deed, if the CD8 T cells are allowed to rest in the ab-
sence of antigen, they recover their antigenic respon-
siveness. Furthermore, they also regain their ability to
undergo tolerance, and multiple cycles of exposure to
high-dose antigen interspersed with periods of rest
to regain responsiveness appear to be another effective
approach to ultimately achieve clonal deletion (Red-
mond et al., 2005).
Concluding Remarks
Peripheral tolerance of self-reactive CD8 T cells re-
mains an attractive goal to prevent autoimmunity and
allograft rejection. Exposure of CD8 T cells to antigen
Immunity
282Kin the absence of costimulation has been one approach
Hused to achieve this goal (Wekerle et al., 2002). How-
iever, in the case of allograft rejection, the conditions
E
that have been used generally promote anergy, rather
B
than deletion, of the undesired cells. This results in the a
requirement for persistent treatment with costimulatory a
blockade or immunosuppressive drugs to prevent graft B
rejection. Further understanding of the requirements s
mthat result in deletion rather than anergy would be of
nvalue in developing a more durable solution to this im-
Bportant problem.
tThere is evidence that in the absence of inflammation
(caused by pathogens or activated CD4 cells, CD8 T
o
cells representing all stages of development, naive, ef-
Bfector, and memory, can be deleted (Kreuwel et al.,
L
2002). Developing protocols for antigen presentation R
that can affect such deletion in the clinical setting rep- s
cresents a major challenge. This is further complicated
Nby the fact that variation in the strength of TCR-pMHC
Cinteraction among T cells specific for the same antigen
aresults in a diversity of response characteristics. Un-
cderstanding the essential features required for suc-
6
cessful tolerance of CD4 and CD8 T cells is necessary
Cto achieve this goal.
w
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